Tuesday, January 13, 2015
Lung cancer: Phase III data for Gilotrif (afatinib) published in The Lancet Oncology
… patients with metastatic non-small cell lung cancer (NSCLC). In each trial, patients … patients with EGFR mutations.
"Lung cancer patients with this specific genetic … patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment